Concepedia

Adverse Event Normalization

Adverse Event Normalization is the process of mapping heterogeneous expressions of adverse events reported in clinical or pharmacovigilance data to a standardized medical terminology or ontology, thereby enabling consistent identification, comparison, and analysis of drug safety signals.

12

Publications

806

Citations

76

Authors

45

Institutions

Publications per year

2017–2026

4

Parents

Publications

12

Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up

Nico H.J. Pijls, Uwe Siebert, Eric R. Powers et al. · Circulation · 2002 · 318 citations

, , +17

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

Hans L. Tillmann, Johannes Hadem, Ludger Leifeld et al. · Journal of Viral Hepatitis · 2006 · 209 citations

, , +17

Efavirenz-Associated QT Prolongation and Torsade de Pointes Arrhythmia

Ricardo Castillo, Ronald P. Pedalino, Nabil El‐Sherif et al. · Annals of Pharmacotherapy · 2002 · 58 citations

, , +17

Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity

Erin E. Longbrake, Yang Mao‐Draayer, Mark Cascione et al. · Multiple Sclerosis Journal · 2020 · 43 citations · Full text

, , +16

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers

Hanny Al‐Samkari, Hasan Ahmad Hasan Albitar, Scott E. Olitsky et al. · Orphanet Journal of Rare Diseases · 2019 · 41 citations · Full text

, , +13

1–5 of 12

Authors

76

  1. MS
    Marianne S. Clancy

    Harvard University, United States

    2 publications · 68 citations

    2

    h-index

  2. HA
    Hasan Ahmad Hasan Albitar

    Mayo Clinic in Arizona, United States

    2 publications · 68 citations

    2

    h-index

  3. HA
    Hanny Al‐Samkari

    Massachusetts General Hospital, United States

    2 publications · 68 citations

    2

    h-index

  4. VI
    Vivek Iyer

    Mayo Clinic, United States

    2 publications · 68 citations

    2

    h-index

  5. SE
    Scott E. Olitsky

    Children's Mercy Hospital, United States

    2 publications · 68 citations

    2

    h-index

1–5 of 76

Institutions

45

  1. Harvard University

    Cambridge, United States

    2 h-index

    2 publications

    68 citations

  2. Mayo Clinic in Arizona

    Scottsdale, United States

    2 h-index

    2 publications

    68 citations

  3. Mayo Clinic

    Rochester, United States

    2 h-index

    2 publications

    68 citations

  4. Yale University

    New Haven, United States

    2 h-index

    8 publications

    127 citations

  5. Massachusetts General Hospital

    Boston, United States

    2 h-index

    2 publications

    68 citations

  6. University of Michigan

    Ann Arbor, United States

    1 h-index

    1 publications

    43 citations

  7. Tokyo Women's Medical University

    Tokyo, Japan

    1 h-index

    10 publications

    3.2K citations

  8. University of Thessaly

    Volos, Greece

    1 h-index

    2 publications

    418 citations

1–8 of 45

Venues

  1. Annals of Pharmacotherapy

    3 publications · 87 citations

    3

    h-index

  2. Multiple Sclerosis Journal

    MSJ · 1 publications · 43 citations

    1

    h-index

  3. Haemophilia

    1 publications · 27 citations

    1

    h-index

  4. Journal of Viral Hepatitis

    1 publications · 209 citations

    1

    h-index

  5. 1

    h-index

1–5